A set of pentacyclic triterpenes has been isolated from the bark of Maytenus macrocarpa (Celastraceae). It includes two new olean-12-ene derivatives, namely 3β, 22α-dihydroxy-olean-12-en-30-oic acid (1) and 22α-hydroxy-olean-12-en-3-oxo-30-oic acid (2), and the new urs-12-ene derivative 3-(E)-coumaroyluvaol (7), along with 10 known compounds possessing olean-12-ene, urs-12-ene, lupane and friedelane skeletons. The structures have been elucidated by extensive spectroscopic methods including 1D-and 2D-NMR experiments, as well as ESI-MS analysis. All isolated compounds were tested for anti-HIV activity in C8166 cells infected with HIV-1 MN . The most active compound was 22α-hydroxy-12-en-3-oxo-29-oic acid (triterpenonic acid A, 4), with an EC 50 value of 1 μg/mL and a selectivity index of 35.
Species belonging to the genus Maytenus (Celastraceae) have been used as a traditional medicine in the Amazonian region against cancer, rheumatism, and inflammation [1] [2] . M. macrocarpa (R & P) Briquet is endemic to the Amazonian region of Peru and an alcoholic infusion of its bark is used, generally in "aguardiente", for the treatment of rheumatism, influenza, gastrointestinal diseases, and as an antitumor agent for skin cancer [3] . In previous papers, dammarane [3] and friedelane triterpenes [4] from the stem bark exudates, sesquiterpene polyol esters from the leaves [5] , and the nortriterpenes macrocarpins A-D from the roots [6] of M. macrocarpa have been reported. Furthermore a dihydro-β-agarofuran sesquiterpene isolated from the roots of M. macrocarpa has been reported to act as a modulator of daunomycin resistance in a multidrugresistant Leishmania tropica line. [7] .
Here we report the isolation and characterization of three new triterpenes from the bark of M. macrocarpa, namely 3β, 22α-dihydroxy-12-en-30-oic acid (1), 22α-hydroxy-12-en-3-oxo-30-oic acid (2) and 3-(E)-p-coumaroyluvaol (7), along with the known olean-12-ene derivatives maytenfolic acid (3), triptotriterpenonic acid A (4), 22-epi-maytenfolic acid (5), 22-epi-triptotriterpenonic acid A (6), the urs-12-ene derivative 3-(E)-caffeoyluvaol (8) , the lupane-type triterpenes 3-(E)-p-coumaroylbetulin (9), 3-(Z)-p-coumaroylbetulin (10), 3-(E)-caffeoylbetulin (11), nepeticin (12) , and friedelane orthosphenic acid (13) . On the basis of the anti-HIV activity reported for triterpenes closely related to compounds 1-13 isolated from M. macrocarpa [8] [9] [10] , the inhibitory activity of these compounds against HIV-1 replication in acutely infected C8166 cells has been evaluated. Column chromatography of a CHCl 3 extract of the bark of M. macrocarpa on silica gel, yielded compounds 1-13. 13 C NMR spectroscopic data and comparison with those of 3β,22α-dihydroxy-12-en-29-oic acid (3), known as maytenfolic acid [11] , suggested that the difference between the two compounds should be confined to ring E [12] 
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Natural Product Communications Vol. 1 (12) 2006 1075 allowed us to clarify the difference between the two compounds. While, in the case of 3, the ROESY spectrum showed correlations between the signal at δ 1.22 (Me-30) and the signals at δ 2.36 (H-18), 3.52 (H-22), and 1.01 (Me-28), these effects were absent in the ROESY spectrum of 1, where the signal at δ 1.26 (Me-29) showed a correlation with that at δ 1.33 (Me-27). This evidence led to the conclusion that 1 was 3β,22α-dihydroxy-olean-12-en-30-oic acid, which was named macrocarpoic acid A.
Compound 2 showed, in the ESI-MS in positive ion mode, the quasi-molecular ion [M+H] + at m/z 471, corresponding to the molecular formula C 30 H 46 O 4 . The compound exhibited, in its 1 H NMR spectrum, seven singlet methyl groups (δ 0.95, 1.09, 1.11 x 2, 1.13, 1.26, 1.33), one olefinic proton (δ 5.25), and one methine proton (δ 3.63) linked to an oxygen bearing carbon. In the 13 C NMR spectrum the occurrence of signals for 30 carbons, including peaks at δ 123.4, 143.5, 181.0 and 219.0, suggested that 2 was an oxoolean-12-enoic acid [13] . By comparison of NMR data of 2 with those of 1 it was speculated that the position of the carbonyl group (δ 219.0) was at C-3 on the basis of the absence in 2 of the signals at δ 3.19 in the 1 H NMR spectrum and 79.7 in the 13 C NMR spectrum, observed for 1. It was confirmed by the long range correlations observed in the HMBC spectrum between the proton signals at δ 1.09 (Me-23) and 1.11 (Me-24) and the carbon resonance at δ 219.0 (C-3). Thus 2 was assigned as 22α-hydroxy-olean-12-en-3-oxo-30-oic acid, and named macrocarpoic acid B. 13 C NMR spectroscopic data of 7 were similar to those of urs-12-en-3β,28-diol, known as uvaol [14] , except for the chemical shift of C-3 and the occurrence of an acyl moiety identified as (E)-p-coumaroyl. In the HMBC spectrum, the proton at δ 4.58 (H-3) correlated with the carbon resonance at δ 167.2 (C=O), indicating that the (E)-coumaroyl group was located at C-3. Thus compound 7 was identified as 3-(E)-coumaroyluvaol, and named macrocarpol A.
The known compounds maytenfolic acid (3) [11] , triptotriterpenonic acid A (4) [15] , 22-epimaytenfolic acid (5) [16] , 22-epi-triptotriterpenonic acid A (6) [18] , nepeticin (12) [12] , and orthosphenic acid (13) [12] were identified by comparison of their spectroscopic data with those reported in the literature.
The co-occurrence in M. macrocarpa of triterpenes belonging to different classes is an unusual finding. For maytenfolic acid (3), previously isolated from M. diversifolia [11] , antileukemic activity has been reported [11] , while compounds 9-11, betulin esters, have been reported to exert antitumor promoting activity [19] . Compounds 7-8 are esters of uvaol, for which antiproliferative and antileukemic activity have been reported [20] . EC 50 a = concentration (μg/mL) that reduced by 50% the production of gp120 in infected C8166 cells. TC 50 b = concentration (μg/mL) that caused 50% cytotoxicity to uninfected C8166 cells.
On the basis of the anti-HIV activity reported for the lupane derivative betulinic acid [8] [9] , and, to a minor extent, for salaspermic acid, a friedelane derivative closely related to orthosphenic acid [10] , the anti-HIV activity of compounds 1-13 in C8166 cells infected with HIV-1 MN was tested. The most active compound was 4, with an EC 50 value of 1μg/mL and a selectivity index above 30 (Table 1 ). The investigation of the mechanism of action of 4 revealed that it was more effective when added either
prior to or at the time of virus infection. Further experiments confirmed that it inhibited the binding of gp120 to sCD4 in a dose dependent manner. At a concentration corresponding to its EC 50 , compound 4 inhibited the interaction between gp120 and CD4 by 55%.
The activity exerted by betulin esters (9-11) is very much lower than that reported for betulinic acid and its derivatives by Hashimoto et al. [8] . Also orthosphenic acid (13) showed an anti-HIV activity lower than that reported for salaspermic acid [10] , from which it differs only by the occurrence of a further α-OH group at C-2.
Experimental
General procedures: Optical rotations were measured on a Jasco DIP 1000 polarimeter. UV spectra were obtained on a Beckman DU 670 spectrometer. IR measurements were obtained on a Bruker IFS-48 spectrometer. Melting points were determined using a Bausch & Lomb apparatus. Accurate molecular weights were measured by a Voyager DE mass spectrometer. Samples were analyzed by matrix assisted laser desorption ionization (MALDI) mass spectrometry. A mixture of analyte solution and α-cyano-4-hydroxycinnamic acid (Sigma) was applied to the metallic sample plate and dried. Mass calibration was performed with the ions from ACTH (fragment 18-39) at 2465.1989 Da and Angiotensin III at 931.5154 Da as internal standards. ESI-MS analyses were performed using a ThermoFinnigan LCQ Deca XP Max ion trap mass spectrometer equipped with Xcalibur software. NMR experiments were performed on a Bruker DRX-600 spectrometer at 300 K. All the 2D-NMR spectra were acquired in CD 3 OD. Standard pulse sequence and phase cycling were used for DQF-COSY, HSQC, HMBC and ROESY spectra. TLC was performed on silica gel F254 (Merck) plates, and reagent grade chemicals (Carlo Erba) were used throughout.
Plant material:
Maytenus macrocarpa was collected in the Ucayali Region (Pucallpa), Peru. A voucher specimen is deposited at the Department of Pharmaceutical Sciences, Salerno, Italy.
Extraction and isolation:
The dried and powdered bark of M. macrocarpa (310 g) was defatted with light petroleum and then extracted by maceration at room temperature with CHCl 3 until exhaustion. The CHCl 3 extract was concentrated under reduced pressure to a syrupy consistency (2.5 g). The crude extract was chromatographed on a silica gel column using CHCl 3 
Antiviral assays:
The anti-HIV activity and toxicity of compounds 1-13 were assessed in C8166 cells infected with HIV-1 MN . Cells were cultured in RPMI 1640 with 10% fetal calf serum. Forty-thousand cells per microtiter plate well were mixed with 5-fold dilutions of compounds prior to addition of 10 CCID 50 units of virus and incubated for 5-6 days. Formation of syncytia was examined from 2 days post-infection. The inhibition of HIV-infection was determined by examining syncytia, by estimating antigen gp120 by ELISA, and by measuring cell viability for virus-infected cells and uninfected cell controls using the XTT-formazan method.
Virus infectivity assay:
The total progeny virus was titrated in microtiter plates using double dilutions of freshly collected supernatants and C8166 cells. The end point was determined by examining syncytia formation and by the XTT-formazan method. Virus titer (CCID 50 ) is expressed as the reciprocal of the dilution that gave a 50% end point. To measure the effects of compounds on virus infectivity, HIV-1 MN (10 4 -10 5 CCID 50 ) was incubated with test compound at 37°C for 1h, the virus was serially diluted, and the infectivity end-point determined.
Gp120-sCD4 interaction assay: Gp120-sCD4 interaction was measured by ELISA; sCD4 was bound to microtiter plate wells at a concentration of 0.05 μg/well. Various dilutions of compounds were mixed with equal volumes of recombinant gp120 (0.04 μg/mL) and added to CD4 coated wells. After incubation at 37°C for 3-5 h, the binding of gp120 was detected using human anti-HIV serum and antihuman Ig conjugated to horseradish peroxidase.
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Using WIACALC (Pharmacia LKB), the percent inhibition was calculated from linear logarithmic plots using three concentrations of gp120 alone as standard. 
Macrocarpoic acid

